Drug factory · FDA FEI 3006687027
Takeda Ireland Limited
Grange Castle Business Park, Nangor Road, Dublin, Ireland
Problems found, fixed voluntarily at FDA's last inspection, Jul 14, 2023.
Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.
3 drug inspections on record since 2013: 2 with no problems, 1 with problems fixed voluntarily, 0 with FDA action.
What it does, for whom
| Drug | Role | For | NDC |
|---|---|---|---|
| Metformin and Pioglitazone | Makes it | Takeda Pharmaceuticals America, Inc. | 64764-158 |
FDA inspection history
| Ended | Result | Program | Problems noted |
|---|---|---|---|
| Jul 14, 2023 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| May 26, 2016 | No problems found | Drug Quality Assurance | — |
| Jun 20, 2013 | No problems found | Drug Quality Assurance | — |
Registered with FDA for: analysis; api manufacture; label; manufacture; pack.